⌘K

Login Start Free

Home/Filings/4/0000950170-25-074289

4//SEC Filing

Katkin Keith 4

Accession 0000950170-25-074289

CIK 0001395937other

View on SEC.gov Company Profile

Filed

May 18, 8:00 PM ET

Accepted

May 19, 4:01 PM ET

Size

4.4 KB

Accession

0000950170-25-074289

Insider Transaction Report

Form 4

Period: 2025-05-19

Syndax Pharmaceuticals IncSNDX

Director

Transactions

Purchase
Common Stock
2025-05-19$9.11/sh+10,000$91,120→ 100,000 total

Documents

1 file

4
ownership.xmlPrimary
4

Issuer

Syndax Pharmaceuticals Inc

CIK 0001395937

Entity typeother

Related Parties

1

filerCIK 0001314596

Filing Metadata

Form type: 4
Filed: May 18, 8:00 PM ET
Accepted: May 19, 4:01 PM ET
Size: 4.4 KB

View on SEC.gov